Characteristics and co-morbidities associated with hospital discharges for opioid and methamphetamine co-use, United States 2016–2019

Characteristics and co-morbidities associated with hospital discharges for opioid and methamphetamine co-use, United States 2016–2019

Introduction: The US overdose crisis is increasingly characterized by opioid and methamphetamine co-use. Hospitalization is an important opportunity to engage patients in substance use treatment. Understanding characteristics of co-use-related hospital stays can inform the development of services to...

Full description

Bibliographic Details
Main Authors:	Riley D. Shearer, Nathan D. Shippee, Beth A. Virnig, Timothy J. Beebe, Tyler N.A. Winkelman
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	Drug and Alcohol Dependence Reports
Subjects:	Opioid Methamphetamine Polysubstance use Hospital Addiction medicine services Substance use treatment
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772724624000039

Similar Items

Opioid, methamphetamine, and polysubstance use: perinatal outcomes for the mother and infant
by: Trecia A. Wouldes, et al.
Published: (2023-12-01)

Identifying behaviours for survival and wellness among people who use methamphetamine with opioids in British Columbia: a qualitative study
by: Jenny Corser, et al.
Published: (2022-05-01)

The motives and methods of methamphetamine and ‘heroin’ co-use in West Virginia
by: Jeff Ondocsin, et al.
Published: (2023-07-01)

The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition
by: Jeffrey M. Rogers, et al.
Published: (2023-03-01)

Editorial: Broadening the scope of addiction medicine: Integrating co-morbid conditions, polysubstance use, and patient experiences into substance use treatment
by: Matthew S. Ellis, et al.
Published: (2022-11-01)

Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use
by: Jarratt D. Pytell, et al.
Published: (2023-09-01)

Novel RNA-Seq Signatures Post-Methamphetamine and Oxycodone Use in a Model of HIV-Associated Neurocognitive Disorders
by: Pranavi Athota, et al.
Published: (2023-09-01)

Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities
by: Angela T. Estadt, et al.
Published: (2024-11-01)

Polysubstance use and post-discharge mortality risk among hospitalized patients with opioid use disorder
by: Karli R. Hochstatter, et al.
Published: (2023-12-01)

Histone modifications in cocaine, methamphetamine and opioids
by: Junzhe Cheng, et al.
Published: (2023-06-01)

The Effectiveness of Mindfulness in the Treatment of Methamphetamine Addiction Symptoms: Does Neuroplasticity Play a Role?
by: James Chmiel, et al.
Published: (2024-03-01)

Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings
by: Madeline C. Frost, et al.
Published: (2023-05-01)

Patterns of and Rationale for the Co-use of Methamphetamine and Opioids: Findings From Qualitative Interviews in New Mexico and Nevada
by: Brittany D. Rhed, et al.
Published: (2022-03-01)

Potency-Enhancing Synthetics in the Drug Overdose Epidemic: Xylazine (“Tranq”), Fentanyl, Methamphetamine, and the Displacement of Heroin in Philadelphia and Tijuana
by: Fernando Montero, et al.
Published: (2022-12-01)

Prevalence and correlates of using opioids alone among individuals in a residential treatment program in Michigan: implications for overdose mortality prevention
by: Rachel E. Gicquelais, et al.
Published: (2022-12-01)

The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review
by: Cayley Russell, et al.
Published: (2023-08-01)

Opioid-related polysubstance use and its effect on mortality and health resource utilization among trauma patients
by: Safalta Khadka, et al.
Published: (2023-10-01)

Multiple memory object-drug association task (MODAT) for the study of polydrug associations
by: Madalyn Hafenbreidel, et al.
Published: (2025-06-01)

Buprenorphine involvement in opioid overdose deaths: A retrospective analysis of postmortem toxicology in Marion County, Indiana, 2015-2021
by: Brandon del Pozo, et al.
Published: (2023-03-01)

Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment
by: Yue Pan, et al.
Published: (2022-12-01)

THE PROFILE OF OPIOID–DEPENDENT PATIENTS REFERRED TO SEMBADA HOSPITAL, MEDAN, INDONESIA
by: DATTEN BANGUN, et al.
Published: (2006-01-01)

Relationship of the emergency department presentation frequency of patients using methamphetamine with the COVID-19 pandemic
by: Fatma Cakmak
Published: (2023-06-01)

Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder
by: Jonathan Brett, et al.
Published: (2023-03-01)

Can the type of subjective response to first opioid exposure predict the risk of opioid use disorder? A scoping review
by: Christian J. Morris, et al.
Published: (2022-10-01)

The influence of transformations in supply on methamphetamine initiation among people injecting opioids in the United States
by: Sarah Mars, et al.
Published: (2024-03-01)

Multiple Substance Use Disorders and Self-Reported Cognitive Function in U.S. Adults: Associations and Sex-Differences in a Nationally Representative Sample
by: Zoe Bourgault, et al.
Published: (2022-01-01)

Motivation and context of concurrent stimulant and opioid use among persons who use drugs in the rural United States: a multi-site qualitative inquiry
by: R. J. Fredericksen, et al.
Published: (2024-04-01)

The four-factor personality model and its qualitative correlates among opioid agonist therapy clients
by: Ioan T. Mahu, et al.
Published: (2023-06-01)

“Just another thing for me to stress off of”: Responses to unintentional fentanyl use in a community-based study of people who use opioids
by: Jennifer Lorvick, et al.
Published: (2023-09-01)

Trends in opioid overdose fatalities in Cuyahoga County, Ohio: Multi-drug mixtures, the African-American community and carfentanil
by: Manreet K. Bhullar, et al.
Published: (2022-09-01)

Trends in Israeli community-based opioid prescribing, 2010–2020, an observational study of the country’s largest HMO
by: Reuven L. Dressler, et al.
Published: (2023-11-01)

The impact of polysubstance use patterns on engagement of substance use disorder treatment among emergency department patients at high risk of opioid overdose
by: Fiona Bhondoekhan, et al.
Published: (2023-12-01)

Intentional use of both opioids and cocaine in the United States
by: Xiguang Liu, et al.
Published: (2023-06-01)

The distinct role of kappa opioid receptor in attenuating relapse to morphine/methamphetamine (polydrug) dependence in mice
by: Irna Elina Ridzwan, et al.
Published: (2018-07-01)

A legal dispute resolution intervention for patients with substance use disorders: a study protocol for a randomized controlled trial
by: Meghan M. O’Neil, et al.
Published: (2023-03-01)

Treatment setting among individuals with opioid use and criminal legal involvement, housing instability, or Medicaid insurance, 2015-2021
by: Riley D. Shearer, et al.
Published: (2023-09-01)

Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use
by: Jonathan Brett, et al.
Published: (2024-12-01)

Modeling functional brain connections in methamphetamine and opioid abusers
by: Nasimeh Marvi, et al.
Published: (2024-03-01)

Spontaneous pneumomediastinum: A rare complication of methamphetamine use
by: Jessica Albanese, et al.
Published: (2017-01-01)

Correlates of Aggression in Men With Methamphetamine Use Disorder: Childhood Trauma and Methamphetamine-Use Characteristics
by: Mengqi Liu, et al.
Published: (2022-05-01)